Presentations Medicenna Therapeutics Corp. - Corporate Presentation Q1 2023 Upcoming Events February 7, 2023 at 8:30 AM EST Medicenna Therapeutics Corp. Third Quarter Fiscal 2023 Earnings Call Go to February 9, 2023 at 3:55 PM EST 2023 Guggenheim Oncology Conference Go to Past Events November 3, 2020 at 9:50 AM EST Next-Gen Cytokine Therapeutics Summit Go to October 29, 2020 from 11:00 AM to 12:30 PM EDT Virtual TSX Life Sciences Investor Day Go to October 24 - October 25, 2020 MDNA55, a Locally Administered IL4 Guided Toxin for Targeted Treatment of Recurrent Glioblastoma Shows Long Term Survival Benefit Go to October 24 - October 25, 2020 Emergence of Novel Long-acting Mono- and Bi-specific IL-2/IL-13 Superkines as Potent Immune Modulators Go to October 1, 2020 at 12:30 PM EDT Virtual Gravitas Healthcare Investor Day Go to September 30, 2020 at 10:00 AM EDT Medicenna Annual and Special Meeting Go to Pagination First page « first Previous page ‹ previous … Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Current page 9 Page 10 Page 11 Next page next › Last page last »
February 7, 2023 at 8:30 AM EST Medicenna Therapeutics Corp. Third Quarter Fiscal 2023 Earnings Call Go to
October 24 - October 25, 2020 MDNA55, a Locally Administered IL4 Guided Toxin for Targeted Treatment of Recurrent Glioblastoma Shows Long Term Survival Benefit Go to
October 24 - October 25, 2020 Emergence of Novel Long-acting Mono- and Bi-specific IL-2/IL-13 Superkines as Potent Immune Modulators Go to
